Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06505382
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-06-14
Brief Title:
Effects of Percutaneous Neuromouldation of the Saphenous Nerve in Patients With Patellofemoral Pain
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effects of Ultrasound-Guided Percutaneous Neuromodulation of the Saphenous Nerve for Pain Management and Functionality in Patellofemoral Pain Syndrome Patients A Single-Blind Randomized Controlled Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PNMSNPFP
Brief Summary:
The knee is a common source of musculoskeletal pain with patellofemoral pain PFP standing out due to its high prevalence This pain frequent in adolescents and athletes significantly impacts the quality of life by hindering daily activities such as climbing stairs and sitting for extended periods Percutaneous neuromodulation of the saphenous nerve PNM emerges as a promising therapeutic approach in physiotherapy to alleviate these symptoms
A randomized controlled clinical trial is proposed in adults with PFP Participants will be divided into two groups one will receive PNM of the saphenous nerve while the other will be a control group receiving puncture without electrical stimulation Pain extension strength and knee range of motion will be evaluated before and after the intervention using the AKPS scale Three sessions will be conducted with specific intervals and a follow-up assessment will be performed three months later
A randomized controlled clinical trial is proposed in adults with PFP Participants will be divided into two groups one will receive PNM of the saphenous nerve while the other will be a control group receiving puncture without electrical stimulation Pain extension strength and knee range of motion will be evaluated before and after the intervention using the AKPS scale Three sessions will be conducted with specific intervals and a follow-up assessment will be performed three months later
Detailed Description:
Introduction The knee is a common source of musculoskeletal pain with patellofemoral pain PFP being one of the most prevalent The incidence of PFP varies with age and activity level but its impact on quality of life by causing pain and reduced functionality is significant A high prevalence has been observed in adolescents and athletes with symptoms interfering in daily activities such as climbing stairs squatting or sitting for prolonged periods Percutaneous neuromodulation of the saphenous nerve emerges as a promising therapeutic approach to improve these patients symptoms within the scope of physiotherapy
Objectives To determine the efficacy of a physiotherapy protocol based on ultrasound-guided percutaneous neuromodulation of the saphenous nerve on functional performance and pain in patients with PFP
Materials and Methods A randomized controlled clinical trial is proposed in adults with PFP symptoms Volunteers will be divided into two groups an intervention group and a control group The experimental group will receive ultrasound-guided percutaneous neuromodulation PNM of the saphenous nerve while the control group will only receive nerve puncture without electrical stimulation The AKPS scale will be used to evaluate pain before and after the intervention as well as knee extension strength and range of motion Three sessions will be conducted with a one-week interval between the first two and a two-week interval between the second and third sessions Finally a follow-up assessment of all items without intervention will be conducted at three months
Objectives To determine the efficacy of a physiotherapy protocol based on ultrasound-guided percutaneous neuromodulation of the saphenous nerve on functional performance and pain in patients with PFP
Materials and Methods A randomized controlled clinical trial is proposed in adults with PFP symptoms Volunteers will be divided into two groups an intervention group and a control group The experimental group will receive ultrasound-guided percutaneous neuromodulation PNM of the saphenous nerve while the control group will only receive nerve puncture without electrical stimulation The AKPS scale will be used to evaluate pain before and after the intervention as well as knee extension strength and range of motion Three sessions will be conducted with a one-week interval between the first two and a two-week interval between the second and third sessions Finally a follow-up assessment of all items without intervention will be conducted at three months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None